The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.
Allergy and Immunology
/ education
Antibodies, Monoclonal, Humanized
/ pharmacology
Atherosclerosis
/ drug therapy
Databases, Pharmaceutical
Drug Development
Drug Discovery
Humans
Immune System
/ diagnostic imaging
Immunologic Factors
/ pharmacology
Inflammation Mediators
/ metabolism
International Cooperation
Molecular Targeted Therapy
/ methods
Pharmaceutical Research
/ education
Pharmacology, Clinical
/ education
Randomized Controlled Trials as Topic
Signal Transduction
/ drug effects
Societies, Scientific
/ organization & administration
Treatment Outcome
database
immune-therapeutics
immunopharmacology
pharmacology
Journal
Immunology
ISSN: 1365-2567
Titre abrégé: Immunology
Pays: England
ID NLM: 0374672
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
03
12
2019
revised:
17
01
2020
accepted:
27
01
2020
pubmed:
6
2
2020
medline:
20
11
2020
entrez:
6
2
2020
Statut:
ppublish
Résumé
Given the critical role that the immune system plays in a multitude of diseases, having a clear understanding of the pharmacology of the immune system is crucial to new drug discovery and development. Here we describe the International Union of Basic and Clinical Pharmacology (IUPHAR) Guide to Immunopharmacology (GtoImmuPdb), which connects expert-curated pharmacology with key immunological concepts and aims to put pharmacological data into the hands of immunologists. In the pursuit of new therapeutics, pharmacological databases are a vital resource to researchers through providing accurate information on the fundamental science underlying drug action. This extension to the existing IUPHAR/British Pharmacological Society Guide to Pharmacology supports research into the development of drugs targeted at modulating immune, inflammatory or infectious components of disease. To provide a deeper context for how the resource can support research we show data in GtoImmuPdb relating to a case study on the targeting of vascular inflammation.
Identifiants
pubmed: 32020584
doi: 10.1111/imm.13175
pmc: PMC7160657
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
Immunologic Factors
0
Inflammation Mediators
0
canakinumab
37CQ2C7X93
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
10-23Subventions
Organisme : Wellcome Trust
ID : 108420/Z/15/Z
Pays : United Kingdom
Informations de copyright
© 2020 The Authors. Immunology published by John Wiley & Sons Ltd.
Références
Gastroenterol Res Pract. 2016;2016:2097274
pubmed: 28070181
Immun Ageing. 2018 Mar 2;15:11
pubmed: 29507595
Semin Cell Dev Biol. 2019 Feb;86:77-88
pubmed: 29454038
Nucleic Acids Res. 2013 Jan;41(Database issue):D1083-8
pubmed: 23087376
Clin Neurosci. 1994;2(3-4):229-45
pubmed: 7749893
Br J Pharmacol. 2017 Jul;174(13):1875-1880
pubmed: 28299772
Br J Pharmacol. 2016 Mar;173(5):793-803
pubmed: 26620589
Nucleic Acids Res. 2019 Jan 8;47(D1):D1102-D1109
pubmed: 30371825
Curr Opin Organ Transplant. 2012 Aug;17(4):376-85
pubmed: 22790072
Front Immunol. 2018 Sep 10;9:2041
pubmed: 30250471
Lancet. 2018 Jan 27;391(10118):319-328
pubmed: 29146124
Br J Pharmacol. 2019 Dec;176 Suppl 1:S1-S20
pubmed: 31710719
Immun Ageing. 2005 May 18;2:8
pubmed: 15904534
Curr Protoc Bioinformatics. 2017 Jun 27;58:1.2.1-1.2.12
pubmed: 28654725
Eur Heart J. 2019 Aug 7;40(30):2492-2494
pubmed: 30929007
Nucleic Acids Res. 2011 Jan;39(Database issue):D534-8
pubmed: 21087994
Immunology. 2008 Oct;125(2):154-60
pubmed: 18798919
Nucleic Acids Res. 2015 Jan;43(Database issue):D789-98
pubmed: 25428349
Nucleic Acids Res. 2019 Jan 8;47(D1):D955-D962
pubmed: 30407550
Genome Biol. 2005;6(2):R21
pubmed: 15693950
Clin Exp Immunol. 2017 Jan;187(1):16-25
pubmed: 27711979
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106
pubmed: 29149325
Circ Res. 2016 Jan 8;118(1):145-56
pubmed: 26837745
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Eur Heart J. 2020 Jun 14;41(23):2153-2163
pubmed: 31504417
Pharmacol Ther. 2017 Feb;170:37-63
pubmed: 27773785
Nat Rev Cardiol. 2018 Apr;15(4):203-214
pubmed: 29143812
Mol Immunol. 2019 Jun;110:40-47
pubmed: 29233542
Br J Pharmacol. 2015 Sep;172(17):4217-27
pubmed: 26173913
Nucleic Acids Res. 2014 Jan;42(Database issue):D1098-106
pubmed: 24234439
Br J Pharmacol. 2017 Nov;174(22):3898-3913
pubmed: 28409825
Transplant Rev (Orlando). 2015 Apr;29(2):103-8
pubmed: 25555541
Ann N Y Acad Sci. 2006 Nov;1089:472-86
pubmed: 17261790
Curr Opin Immunol. 2017 Apr;45:43-51
pubmed: 28192720
Annu Rev Immunol. 2010;28:573-621
pubmed: 20192811
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Curr Opin Rheumatol. 2018 Mar;30(2):215-221
pubmed: 29227354
Lancet. 2017 Jun 10;389(10086):2328-2337
pubmed: 28612747
Br J Pharmacol. 2015 Dec;172(24):5729-43
pubmed: 26650438
Lancet Psychiatry. 2019 Feb;6(2):164-173
pubmed: 30366684
Autoimmun Rev. 2005 Sep;4(7):460-7
pubmed: 16137612
Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954
pubmed: 27899562
Nat Rev Immunol. 2018 Dec;18(12):729
pubmed: 30327546
Bioinformatics. 2007 Apr 1;23(7):913-5
pubmed: 17267433
Nat Immunol. 2016 Jun 21;17(7):775-82
pubmed: 27328007
Br J Pharmacol. 2016 May;173(9):1407-24
pubmed: 26833433
Nucleic Acids Res. 2009 Jan;37(Database issue):D680-5
pubmed: 18948278
N Engl J Med. 2019 Feb 21;380(8):752-762
pubmed: 30415610
Arch Pharm Res. 2015 Dec;38(12):2106-19
pubmed: 26289122
Cardiovasc Res. 2018 Nov 1;114(13):1714-1727
pubmed: 30165574
J Exp Med. 2017 Nov 6;214(11):3219-3238
pubmed: 29021150
Am Heart J. 2013 Aug;166(2):199-207.e15
pubmed: 23895801
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
Front Immunol. 2019 Apr 26;10:910
pubmed: 31105707
Nucleic Acids Res. 2016 Jan 4;44(D1):D1054-68
pubmed: 26464438
Nature. 2015 Jan 15;517(7534):293-301
pubmed: 25592534
Nucleic Acids Res. 2020 Jan 8;48(D1):D1006-D1021
pubmed: 31691834
Br J Pharmacol. 2017 Dec;174 Suppl 1:S360-S446
pubmed: 29055035